Previous 10 | Next 10 |
The new strategic collaboration aims to provide innovative primary packaging to pharmaceutical and biopharmaceutical companies using Recipharm’s proprietary soft mist inhalers. Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, a...
Stevanato Group S.p.A. (NYSE: STVN), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced two separate agreements with BNL BNP Paribas and Cassa Depositi e Prestiti Group (CDP) ...
Stevanato Group S.p.A. (STVN) Q4 2022 Earnings Conference Call March 2, 2023 8:30 AM ET Company Participants Lisa Miles - SVP Investor Relations Franco Stevanato - Executive Chairman Franco Moro - Chief Executive Officer Marco Dal Lago - Chief Financial Officer ...
The following slide deck was published by Stevanato Group S.p.A. in conjunction with their 2023 Q4 earnings call. For further details see: Stevanato Group S.p.A. 2023 Q4 - Results - Earnings Call Presentation
Stevanato Group press release ( NYSE: STVN ): Q4 Non-GAAP EPS of €0.19. Revenue of €292.1M (+25.6% Y/Y). The Company is establishing full year 2023 guidance of revenue in the range of €1.085 billion to €1.115 billion, adjusted diluted EPS ...
- Establishes Fiscal 2023 Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the fourth quart...
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the fourth quarter and fiscal year 2022 on Thurs...
Summary Cryoport has significantly underperformed the broader market over the past several months, largely due to poor earnings and cash flows. The company has excess cash on its books, but this doesn't make it a great prospect when you consider its continued profitability issues. A...
Stevanato Group ( NYSE: STVN ) collaborates with Transcoject for adding cyclic olefin polymer (COP) and cyclic olefin copolymer (COC) PFS to its existing portfolio of solutions providing added value in the customers’ supply chain. Transcoject is a medical device and ph...
Leading drug containment provider to release a unique offering including both COP and COC pre-fillable syringes (PFS), adding to its existing glass PFS portfolio, providing customers with the broadest choice for PFS Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of d...
News, Short Squeeze, Breakout and More Instantly...
Stevanato Group S.p.A. Company Name:
STVN Stock Symbol:
NYSE Market:
Stevanato Group S.p.A. Website:
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that it will issue financial results for the second quarter of 2024 on Tuesday, August 6, 2...
2024-07-04 19:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-24 21:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...